文献速递神经肿瘤

近三十年来治疗技术演变使颅底脑膜瘤患者视觉预后改善:一项系统综述

Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review.
PubMed 文献 · J Neurooncol · 2023-06-24

该系统综述纳入50项研究、共2911例颅底脑膜瘤患者,评估近三十年来视觉预后变化。2006年及以后发表的单纯手术研究视觉改善优于2006年前研究(p=0.02),2008年及以后发表的手术联合放疗研究视觉改善优于2008年前研究(p<0.01)。联合治疗较单纯手术或单纯放疗更不易导致视力恶化(p<0.01),但单纯手术或单纯放疗在适应证下视觉改善率更高(p<0.01)。

要点

  • 2006年及以后发表的单纯手术研究视觉改善优于2006年前研究(p=0.02)。
  • 2008年及以后发表的手术联合放疗研究视觉改善优于2008年前研究(p<0.01)。
  • 联合治疗更不易导致视力恶化,但适应证下单纯治疗视觉改善率更高(p<0.01)。

核心结论

  • 十余年来颅底脑膜瘤患者视觉预后改善,可能归因于显微外科及更精准适形放疗技术的创新。
  • 联合治疗可能是防止视力恶化的最安全选择,但在有适应证时单纯治疗可获得最高的视觉功能改善率。

研究设计与样本

  • 系统综述,遵循PRISMA指南,检索PubMed和Web of Science,检索时间为2022年6月1日至2022年9月1日。
  • 纳入标准包括:颅底脑膜瘤治疗患者、明确治疗方式、手术技术和/或放疗剂量/分次的细节、个体患者治疗结局。
  • 共纳入50项研究,N=2911例患者。
  • 每项研究基于研究设计和结果异质性评估偏倚。

主要发现

  • 比较视觉改善与视觉未变或恶化,2006年及以后发表的单纯手术研究视觉预后显著优于2006年前研究(p=0.02)。
  • 比较视觉改善与视觉未变或恶化,2008年及以后发表的手术联合放疗研究视觉预后显著优于2008年前研究(p<0.01)。
  • 联合治疗较单纯手术或单纯放疗更不易导致视力恶化(p<0.01)。
  • 单纯手术和单纯放疗较联合治疗更可能实际改善视觉结局(p<0.01)。

临床怎么用

  • 作者认为联合治疗可能是防止视力恶化的最安全选择。
  • 作者指出在有适应证时单纯治疗可获得最高的视觉功能改善率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We systematically reviewed visual outcomes over the last three decades in patients undergoing treatment for base of skull (BOS) meningiomas and provide recommendations to preserve vision. METHODS: In accordance with the PRISMA guidelines for systematic reviews, a search was conducted from 6/1/2022-9/1/2022 using PubMed and Web of Science. Inclusion criteria included (1) patients treated for BOS meningiomas (2) treatment modality specified (3) specifics of surgical techniques and/or dose/fractions of radiotherapy (4) individual patient outcomes of treatment. Each study was assessed for bias based on study design and heterogeneity of results. RESULTS: A total of 50 studies were included (N = 2911). When comparing improved vision versus unchanged or worsened vision, studies investigating surgery alone published from 2006 and onward had significantly better visual outcomes compared to pre-2006 studies (p = 0.02). When comparing improved vision versus unchanged or worsened vision, studies investigating combined therapy with surgery and radiation published from 2008 and onward had significantly better visual outcomes compared to pre-2008 studies (p < 0.01). Combined modality therapy was less likely to worsen vision compared to either surgery or radiation monotherapy (p < 0.01). However, surgery and radiation monotherapy were more likely to actually improve outcomes compared to combination therapy (p < 0.01). CONCLUSION: For over a decade we have observed improvement in visual outcomes in patients managed for meningioma of BOS, likely attributing the innovation in microsurgical and more targeted and conformal radiation techniques. Combination therapy may be the safest option for preventing worsening of vision, but the highest rates of improving visual function are achieved through monotherapy when indicated.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Holdaway M, Starner J, Patel RR, et al. Improvement in visual outcomes of patients with base of skull meningioma as a result of evolution in the treatment techniques in the last three decades: a systematic review. J Neurooncol. 2023. PMID: 37354356. doi:10.1007/s11060-023-04366-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。